• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. VASCUTRAK PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. VASCUTRAK PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number V184040
Medical Device Problem Codes Material Rupture (1546); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/23/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history record is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiry date: 08/2022).
 
Event or Problem Description
It was reported that during an angioplasty procedure of calcified target lesion in the superficial femoral artery via ipsilateral approach, the pta balloon allegedly ruptured at 6atm.It was further reported that another device was used to complete the procedure.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one vascutrak catheter was returned for the evaluation.Visual evaluation was performed and noted that device appeared to be bloody.During the functional test, an in-house presto inflation device was used to inflate the balloon and it was noticed that water was exiting near the distal end of the balloon.Then microscopic evaluation was performed and pinhole rupture was noted near to distal tip portion of the balloon.Therefore, the investigation is confirmed for the reported balloon rupture , as pinhole balloon rupture was noted during the microscopic evaluation.Per the reported event details, the target lesion was calcified.Therefore, it is possible the interaction between the lesion and the balloon contributed to the reported balloon rupture.However, the definitive root cause for the reported balloon rupture could not be determined based upon available information.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during an angioplasty procedure of calcified target lesion in the superficial femoral artery via ipsilateral approach, the pta balloon allegedly ruptured at 6atm.It was further reported that another device was used to complete the procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VASCUTRAK PTA DILATATION CATHETER
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key10873407
Report Number2020394-2020-20510
Device Sequence Number17094605
Product Code PNO
UDI-Device Identifier00801741061530
UDI-Public(01)00801741061530
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K103459
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberV184040
Device Catalogue NumberV184040
Device Lot NumberGFDU3978
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/14/2020
Initial Date Received by Manufacturer 10/24/2020
Supplement Date Received by Manufacturer03/31/2021
Initial Report FDA Received Date11/20/2020
Supplement Report FDA Received Date04/23/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-